F/M Investments’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.33M Buy
55,529
+1,349
+2% +$147K 0.42% 53
2026
Q1
$5M Sell
54,180
-4,387
-7% -$440K 0.33% 64
2025
Q4
$5.98M Buy
58,567
+11,363
+24% +$1.02M 0.23% 107
2025
Q3
$2.95M Buy
47,204
+8,105
+21% +$441K 0.11% 188
2025
Q2
$2.03M Buy
39,099
+471
+1% +$21K 0.07% 239
2025
Q1
$1.65M Buy
+38,628
New +$1.67M 0.07% 253

Other funds holding GH

F/M Investments's GH Position: Q2 2026 in Review

F/M Investments increased its Guardant Health (GH) stake by 2.5% in Q2 2026, buying an estimated $147K and bringing the position to 55,529 shares worth $8.33M. The position accounts for 0.42% of the portfolio, ranked #53.

F/M Investments first reported a position in GH in Q1 2025 and has held it in 6 quarters since. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • F/M Investments held 55,529 shares of Guardant Health worth $8.33M as of Q2 2026.
  • F/M Investments bought 1,349 Guardant Health shares in Q2 2026, an estimated $147K.
  • Guardant Health made up 0.42% of F/M Investments's portfolio in Q2 2026, its #53 holding.
  • F/M Investments first reported a position in Guardant Health in Q1 2025 and has held it in 6 quarters since.
  • 598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on F/M Investments's 13F filing for Q2 2026, filed 5 Aug 2026.